Stage IB and IIA cervical cancer with negative lymph nodes: The role of adjuvant radiotherapy after radical hysterectomy

Gynecologic Oncology

Volumn 66, Issue 1, 1997, Pages 31-35

  Schorge, John O ^a,b   Molpus, Kelly L ^a   Koelliker, Daniel ^a   Nikrui, Najmosama ^a   Goodman, Annekathryn ^a   Fuller Jr , Arlan F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 0031193399     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4691     Document Type: Article

References (19)

1. Barter J F, Soong S J, Shingleton H M, Hatch K D, Orr J W. Complications of combined radical hysterectomy-postoperative radiation therapy in women with early stage cervical cancer. Gynecol Oncol. 32:1989;292-296.
2. Hsu C, Cheng Y, Su S. Prognosis of uterine cervical cancer with extensive lymph node metastases. Am J Obstet Gynecol. 114:1972;954-962.
3. Piver M S, Chung W S. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol. 46:1975;507-510.
4. Morrow C P. Panel report: Is pelvic radiation beneficial in the postoperative management of stage IB squamous cell carcinoma of the cervix with pelvic node metastases treated by radical hysterectomy and pelvic lymphadenectomy? Gynecol Oncol. 10:1980;105-110.
5. Burke T W, Hoskins W J, Heller P B, Bibro M C, Weiser E B, Park P C. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol. 26:1987;153-159.
6. Fuller A F Jr., Elliott N, Kosloff C, Hoskins W J, Lewis J L. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol. 33:1989;34-39.
7. Smiley L M, Burke T W, Silva E G, Morris M, Gershenson D M, Wharton J T. Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence. Obstet Gynecol. 77:1991;271-275.
8. Delgado G, Bundy B, Zaino R, Sevin B, Creasman W T, Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 38:1990;352-357.
9. Creasman W T. FIGO news. Modifications in the staging for stage I vulvar and stage I cervical cancer. Int J Gynecol Obstet. 50:1995;215-216.
10. Eifel P J, Morris M, Wharton J T, Oswald M J. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 29:1994;9-16.
11. Finan M A, DeCesare S, Fiorica J V, Chambers R, Hoffman M S, Kline R C, Roberts W S, Cavanagh D. Radical hysterectomy for stage IB1 vs IB2 carcinoma of the cervix: does the new staging system predict morbidity and survival? Gynecol Oncol. 62:1996;139-147.
12. Schorge J O, Molpus K L, Fuller A F Jr. Stage IB and IIA cervical cancer with lymph node metastases. J Gynecol Tech. 3:1997;1-5.
13. Soisson A P, Soper J T, Clarke-Pearson D L, Berchuck A, Montana G, Creasman W T. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol. 37:1990;390-395.
14. Kinney W K, Alvarez R D, Reid G C, Schray M F, Soong S, Morley G W, Podratz K C,Shingleton H M. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy forearly-stage squamous carcinoma of the cervix with pelvic nodal metastasis: a matched-controlstudy. Gynecol Oncol. 34:1989;258-262.
15. van Nagell J R Jr., Donaldson E S, Wood E G, Parker J C Jr. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer. 41:1978;228-234.
16. Buckley S L, Tritz D M, Van Le L, Higgins R, Sevin B U, Ueland F R, DePriest P D, Gallion H H, Bailey C L, Kryscio R J, Fowler W, Averette H, van Nagell J R. Lymph node metastases and prognosis in patients with stage IA2 cervical cancer. Gynecol Oncol. 63:1996;4-9.
17. Vavra N, Sevelda P, Seifert M, Timar J, Kudielka I, Kucera H. The value of adjuvant irradiation in lymphatic vessel invasion in patients with a cervical carcinoma in histopathological stage Ib and with negative lymph nodes. Strahlenther Onkol. 168:1992;524-527.
18. Hogan W M, Littman P, Griner L, Miller C L, Mikuta J J. Results of radiation therapy given after radical hysterectomy. Cancer. 49:1982;1278-1285.
19. Terada K Y, Morley G W, Roberts J A. Stage IB Carcinoma of the cervix with lymph node metastases. Gynecol Oncol. 31:1988;389-395.